Organon & Co. (OGN)
8.10
+0.58
(+7.71%)
USD |
NYSE |
Feb 20, 16:00
8.12
+0.02
(+0.25%)
After-Hours: 20:00
Organon SG&A Expense (Quarterly) : 433.00M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Amphastar Pharmaceuticals, Inc. | 50.97M |
| Plus Therapeutics, Inc. | 3.443M |
| Geron Corp. | 39.00M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |